Wednesday , December 11 2019
Home / le News / Drug spending continues to explode in Switzerland

Drug spending continues to explode in Switzerland

Summary:
Last week, the government announced that it had shaved CHF 100 million off the cost of drug purchases from 1 January 2020. © Vitaly Iskakov | Dreamstime.com This week numbers obtained by RTS from Curafutura, a health insurance association, show drug spending rose CHF 420 million from CHF 6.9 billion to CHF 7 billion between October 2018 and September 2019 and the same period 12 month a year before. Over the last five years spending on drugs has risen 26%. Savings are not keeping up with runaway costs. The challenge is twofold. The government says that new expensive treatments are constantly being added, new cancer treatments in particular. According to Andreas Schiesser, a spokesperson for Curafutura, the discounts demanded by the Federal Office of Public Health (FOPH) are too

Topics:
Investec considers the following as important: , , , ,

This could be interesting, too:

Investec writes Another month of falling prices in Switzerland

Investec writes Some Swiss import duties could be axed

Investec writes Switzerland’s skilled worker shortage worsens

Investec writes Another month of falling prices in Switzerland

Last week, the government announced that it had shaved CHF 100 million off the cost of drug purchases from 1 January 2020.

Drug spending explodes in Switzerland
© Vitaly Iskakov | Dreamstime.com

This week numbers obtained by RTS from Curafutura, a health insurance association, show drug spending rose CHF 420 million from CHF 6.9 billion to CHF 7 billion between October 2018 and September 2019 and the same period 12 month a year before.

Over the last five years spending on drugs has risen 26%. Savings are not keeping up with runaway costs.

The challenge is twofold. The government says that new expensive treatments are constantly being added, new cancer treatments in particular. According to Andreas Schiesser, a spokesperson for Curafutura, the discounts demanded by the Federal Office of Public Health (FOPH) are too timid.

Five of the ten most costly drugs were not considered for price reductions. CHF 930 million was spent on these ten drugs alone. Currently, the consumption volume of medicines is not factored in when securing price reductions.

There is no legal basis for deeper discounts on drugs consumed in higher volumes, according to FOPH. However, the Federal Council is looking at the rules around drug discounts and parliament is due to look at issue soon.

More on this:

RTS article (in French) – Take a 5 minute French test now

For more stories like this on Switzerland follow us on Facebook and Twitter.

About Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to our niche client base.

Leave a Reply

Your email address will not be published. Required fields are marked *